MediWound (MDWD) Assets Average (2016 - 2026)
MediWound (MDWD) posted quarterly Assets Average of $90.3 million for Q4 2025, up 21.89% year-over-year from $74.1 million in Q4 2024, and up 11.93% quarter-over-quarter from $80.7 million in Q3 2025.
MediWound (MDWD) Assets Average (2016 - 2026) Analysis & Trends
MediWound's Assets Average history runs 10 years deep, the most recent figure standing at $90.3 million for Q4 2025.
- In Q4 2025, Assets Average rose 21.89% year-over-year to $90.3 million; the TTM figure through Dec 2025 stood at $90.3 million (up 21.89% YoY), while the FY2025 annual figure was $79.9 million, up 14.14% from the prior year.
- Assets Average for Q4 2025 stood at $90.3 million, up from $80.7 million in the prior quarter.
- The five-year high for Assets Average was $90.3 million in Q4 2025, with the low at $21.5 million in Q4 2021.
- The 5-year median for Assets Average is $62.1 million (2024), against an average of $52.4 million.
- The sharpest annual moves came in 2021 and 2023: Assets Average plunged 35.37% in 2021, then jumped 180.23% in 2023.
- MediWound's Assets Average stood at $21.5 million in 2021, then soared by 83.18% to $39.3 million in 2022, then jumped by 69.81% to $66.7 million in 2023, then advanced by 11.05% to $74.1 million in 2024, then increased by 21.89% to $90.3 million in 2025.
- Business Quant data shows MDWD's Assets Average at $90.3 million in Q4 2025, $80.7 million in Q3 2025, and $68.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | MediWound | 169.29 Mn | 138.30 Mn | 337,000.00 | 79.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 79.07 Mn |
| Dec 31, 2025 | 90.34 Mn |
| Sep 30, 2025 | 80.71 Mn |
| Jun 30, 2025 | 68.01 Mn |
| Mar 31, 2025 | 71.26 Mn |
| Dec 31, 2024 | 74.12 Mn |
| Sep 30, 2024 | 66.02 Mn |
| Jun 30, 2024 | 59.84 Mn |
| Mar 31, 2024 | 64.42 Mn |
| Dec 31, 2023 | 66.74 Mn |
| Sep 30, 2023 | 65.69 Mn |
| Jun 30, 2023 | 66.52 Mn |
| Mar 31, 2023 | 59.34 Mn |
| Dec 31, 2022 | 39.30 Mn |
| Sep 30, 2022 | 24.85 Mn |
| Jun 30, 2022 | 23.74 Mn |
| Mar 31, 2022 | 23.06 Mn |
| Dec 31, 2021 | 21.46 Mn |
| Sep 30, 2021 | 24.69 Mn |
| Jun 30, 2021 | 27.95 Mn |